ArticleBMC medical imaging2025
The value of [
Article in BMC medical imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multi-adapter SAM-inspired bronchoscopic image segmentation for lung cancer diagnosis.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the value of Fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography ([
methodsFifty-seven patients (57/1384, 4.1%) diagnosed with SPMs were retrospectively enrolled. The analysis included the following factors: clinical information (sex, age, smoking and drinking history, BMI), site of the second primary tumor, the interval between the diagnoses of the first GI cancer and the SPMs, and histopathology. According to the incidence of SPMs, the patients were divided into lung cancer and non-lung cancer groups. The two groups were compared smoking and drinking history, interval time, distant metastasis, and [
resultsThe most common SPMs of the GI system was lung cancer (47.4%, 27/57). Genetic testing revealed abnormalities in three patients, and the pathological type was adenocarcinoma in all three cases. Among the 57 patients diagnosed with multiple cancers (27 synchronous, 30 metachronous), the lung was the most frequent site for both synchronous and metachronous tumors. Between the lung cancer group and the non-lung cancer group differences in the interval between the first GI, age, distant metastasis rate, SUV
conclusionThe most common SPMs of the GI system was lung cancer. We found that [
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.